United Therapeutics EBITDA Margin 2012-2026 | UTHR

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for United Therapeutics (UTHR) over the last 10 years. The current EBITDA margin for United Therapeutics as of March 31, 2026 is .
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
United Therapeutics EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-12-31 $3.18B $1.58B 49.61%
2025-09-30 $3.13B $1.58B 50.37%
2025-06-30 $3.08B $1.53B 49.64%
2025-03-31 $2.99B $1.48B 49.47%
2024-12-31 $2.88B $1.45B 50.35%
2024-09-30 $2.76B $1.35B 48.82%
2024-06-30 $2.62B $1.32B 50.59%
2024-03-31 $2.50B $1.31B 52.46%
2023-12-31 $2.33B $1.24B 53.18%
2023-09-30 $2.21B $1.15B 52.29%
2023-06-30 $2.11B $1.14B 53.98%
2023-03-31 $1.98B $1.03B 51.92%
2022-12-31 $1.94B $1.03B 53.28%
2022-09-30 $1.86B $1.03B 55.11%
2022-06-30 $1.79B $0.94B 52.49%
2022-03-31 $1.77B $0.96B 54.21%
2021-12-31 $1.69B $0.61B 35.94%
2021-09-30 $1.66B $0.50B 30.31%
2021-06-30 $1.59B $0.49B 31.05%
2021-03-31 $1.51B $0.41B 27.36%
2020-12-31 $1.48B $0.64B 43.36%
2020-09-30 $1.41B $0.64B 45.49%
2020-06-30 $1.43B $0.60B 42.21%
2020-03-31 $1.44B $0.68B 47.33%
2019-12-31 $1.45B $-0.14B -9.79%
2019-09-30 $1.52B $-0.08B -5.00%
2019-06-30 $1.53B $-0.11B -7.38%
2019-03-31 $1.60B $-0.12B -7.43%
2018-12-31 $1.63B $0.84B 51.72%
2018-09-30 $1.71B $0.85B 49.47%
2018-06-30 $1.75B $1.02B 58.45%
2018-03-31 $1.75B $0.89B 51.00%
2017-12-31 $1.73B $0.85B 49.04%
2017-09-30 $1.67B $0.88B 52.78%
2017-06-30 $1.63B $0.80B 48.81%
2017-03-31 $1.60B $0.99B 62.09%
2016-12-31 $1.60B $1.09B 68.36%
2016-09-30 $1.60B $1.07B 67.34%
2016-06-30 $1.57B $1.22B 77.30%
2016-03-31 $1.51B $1.11B 73.46%
2015-12-31 $1.47B $0.73B 49.93%
2015-09-30 $1.41B $0.74B 52.74%
2015-06-30 $1.35B $0.33B 24.72%
2015-03-31 $1.33B $0.34B 25.55%
2014-12-31 $1.29B $0.57B 44.41%
2014-09-30 $1.23B $0.38B 31.11%
2014-06-30 $1.20B $0.52B 43.14%
2014-03-31 $1.16B $0.46B 39.97%
2013-12-31 $1.12B $0.34B 30.53%
2013-09-30 $1.07B $0.50B 46.27%
2013-06-30 $1.01B $0.47B 46.54%
2013-03-31 $0.96B $0.45B 47.34%
2012-12-31 $0.92B $0.46B 50.66%
2012-09-30 $0.87B $0.40B 46.14%
2012-06-30 $0.83B $0.42B 51.03%
2012-03-31 $0.79B $0.43B 54.90%
2011-12-31 $0.74B $0.36B 48.66%
2011-09-30 $0.71B $0.31B 43.94%
2011-06-30 $0.68B $0.27B 39.88%
2011-03-31 $0.63B $0.22B 34.24%
2010-12-31 $0.59B $0.21B 35.02%
2010-09-30 $0.53B $0.19B 35.78%
2010-06-30 $0.46B $0.14B 29.85%
2010-03-31 $0.41B $0.07B 16.91%
2009-12-31 $0.36B $0.06B 15.32%
2009-09-30 $0.34B $-0.08B -24.04%
2009-06-30 $0.32B $-0.08B -24.44%
2009-03-31 $0.30B $-0.06B -18.67%
2008-12-31 $0.28B $-0.06B -22.70%
2008-09-30 $0.27B $0.07B 26.32%
2008-06-30 $0.25B $0.06B 24.40%
2008-03-31 $0.23B $0.05B 19.74%
2007-12-31 $0.21B $0.02B 9.48%
2007-09-30 $0.20B $0.02B 9.64%
2007-06-30 $0.18B $0.02B 9.55%
2007-03-31 $0.17B $0.02B 12.65%
2006-12-31 $0.16B $0.03B 19.50%
2006-09-30 $0.14B $0.04B 26.57%
2006-06-30 $0.14B $0.04B 30.15%
2006-03-31 $0.13B $0.04B 32.54%
2005-12-31 $0.12B $0.05B 38.79%
2005-09-30 $0.11B $0.04B 37.96%
2005-06-30 $0.10B $0.03B 33.68%
2005-03-31 $0.08B $0.02B 28.92%
2004-12-31 $0.07B $0.02B 20.27%
2004-09-30 $0.07B $0.01B 7.58%
2004-06-30 $0.06B $0.00B -3.28%
2004-03-31 $0.06B $-0.01B -14.04%
2003-12-31 $0.05B $-0.01B -16.67%
2003-09-30 $0.05B $-0.01B -17.31%
2003-06-30 $0.04B $-0.01B -33.33%
2003-03-31 $0.04B $-0.01B -30.00%
2002-12-31 $0.03B $-0.02B -50.00%
2002-09-30 $0.02B $-0.02B -100.00%
2002-06-30 $0.02B $-0.03B -156.25%
2002-03-31 $0.01B $-0.04B -740.00%
2001-12-31 $0.01B $-0.04B -860.00%
2001-09-30 $0.00B $-0.07B -1625.00%
2001-06-30 $0.00B $-0.06B -2133.33%
2001-03-31 $0.00B $-0.08B -2733.33%
2000-12-31 $0.00B $-0.08B -4000.00%
2000-09-30 $0.00B $-0.07B -7200.00%
2000-06-30 $0.00B $-0.07B -6900.00%
2000-03-31 $0.00B $-0.05B 0.00%
1999-12-31 $0.00B $-0.04B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $25.058B $3.183B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
UCB SA (UCBJY) Belgium $60.713B 0.00
Takeda Pharmaceutical (TAK) Japan $57.538B 11.30
Zoetis (ZTS) United States $49.577B 18.36
Sandoz Group AG (SDZNY) Switzerland $37.136B 0.00
Otsuka Holdings, - (OTSKY) Japan $36.393B 14.73
BeOne Medicines - (ONC) Switzerland $33.976B 83.02
Daiichi Sankyo, - (DSNKY) Japan $33.284B 16.12
Astellas Pharma (ALPMY) Japan $29.805B 11.68
Shionogi (SGIOY) Japan $18.069B 13.97
Merck (MKKGY) Germany $16.944B 11.65
IPSEN (IPSEY) France $16.273B 0.00
Summit Therapeutics (SMMT) United States $15.264B 0.00
Neurocrine Biosciences (NBIX) United States $12.936B 27.96
Ionis Pharmaceuticals (IONS) United States $12.417B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.920B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.749B 16.23
Orion OYJ (ORINY) Finland $10.723B 18.62
Eisai (ESAIY) $9.158B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.834B 16.35
Centessa Pharmaceuticals (CNTA) United Kingdom $6.102B 0.00
Grifols, S.A (GRFS) Spain $5.588B 0.00
Corcept Therapeutics (CORT) United States $4.458B 51.11
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Stevanato Group S.p.A (STVN) Italy $4.094B 22.53
NewAmsterdam Pharma (NAMS) Netherlands $3.997B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.945B 16.50
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $3.838B 0.00
Indivior Pharmaceuticals (INDV) United States $3.724B 12.41
Hypermarcas (HYPMY) Brazil $3.308B 13.82
Dyne Therapeutics (DYN) United States $3.086B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.046B 9.86
Oruka Therapeutics (ORKA) United States $2.952B 0.00
Soleno Therapeutics (SLNO) United States $2.717B 228.83
Enliven Therapeutics (ELVN) United States $2.710B 0.00
Relay Therapeutics (RLAY) United States $2.670B 0.00
Guardian Pharmacy Services (GRDN) United States $2.479B 41.65
BioCryst Pharmaceuticals (BCRX) United States $2.398B 7.19
Nektar Therapeutics (NKTR) United States $2.223B 0.00
Definium Therapeutics (DFTX) United States $2.147B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.096B 19.46
Ocular Therapeutix (OCUL) United States $1.914B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.808B 0.00
Ardelyx (ARDX) United States $1.516B 0.00
Harrow (HROW) United States $1.338B 79.84
Savara (SVRA) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 5.37
Xeris Biopharma Holdings (XERS) United States $1.009B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.971B 0.00
Evotec AG (EVO) Germany $0.935B 0.00
Xencor (XNCR) United States $0.911B 0.00
Aktis Oncology (AKTS) United States $0.901B 0.00
Theravance Biopharma (TBPH) United States $0.842B 21.80
ARS Pharmaceuticals (SPRY) United States $0.799B 0.00
Relmada Therapeutics (RLMD) United States $0.765B 0.00
Bioventus (BVS) United States $0.753B 13.32
Ironwood Pharmaceuticals (IRWD) United States $0.592B 15.78
ProKidney (PROK) United States $0.589B 0.00
Esperion Therapeutics (ESPR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.556B 9.19
Rigel Pharmaceuticals (RIGL) United States $0.540B 4.49
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.487B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 21.37
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
Altimmune (ALT) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 37.99
Century Therapeutics (IPSC) United States $0.404B 0.00
Akebia Therapeutics (AKBA) United States $0.375B 0.00
USANA Health Sciences (USNA) United States $0.334B 9.43
AleAnna (ANNA) United States $0.333B 124.75
Surrozen (SRZN) United States $0.324B 0.00
Siga Technologies (SIGA) United States $0.312B 14.06
Avalo Therapeutics (AVTX) United States $0.311B 0.00
Organogenesis (ORGO) United States $0.306B 8.81
Silence Therapeutics (SLN) United Kingdom $0.271B 0.00
Cybin (HELP) Canada $0.270B 0.00
Protara Therapeutics (TARA) United States $0.268B 0.00
Prelude Therapeutics (PRLD) United States $0.257B 0.00
Minerva Neurosciences (NERV) United States $0.238B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.230B 0.00
MediWound (MDWD) Israel $0.229B 0.00
Context Therapeutics (CNTX) United States $0.229B 0.00
Enlivex (ENLV) Israel $0.228B 0.00
Inhibikase Therapeutics (IKT) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
OmniAb (OABI) United States $0.213B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Korro Bio (KRRO) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Unicycive Therapeutics (UNCY) United States $0.167B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.167B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
VAXART, INC (VXRT) United States $0.152B 10.50
Galectin Therapeutics (GALT) United States $0.151B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
Journey Medical (DERM) United States $0.141B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.115B 0.00
Aldeyra Therapeutics (ALDX) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.088B 0.00
PolyPid (PYPD) Israel $0.082B 0.00
Nuo Therapeutics (AURX) $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
NRx Pharmaceuticals (NRXP) United States $0.073B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.33
SCYNEXIS (SCYX) United States $0.045B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Jupiter Neurosciences (JUNS) United States $0.014B 0.00
Wellgistics Health (WGRX) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Traws Pharma (TRAW) United States $0.012B 0.02
Ainos (AIMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Mannatech (MTEX) United States $0.011B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Liminatus Pharma (LIMN) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00